ZURICH, May 22, 2024
/PRNewswire/ -- Swiss life science innovation will again be on
display at the BIO 2024 convention in San
Diego. Switzerland Global Enterprise will present 41 leading
Swiss biotech stars at the SWISS BIOTECH pavilion demonstrating
Switzerland's key role in the
healthcare sector.
The companies presenting at this year's conference show a wide
range of innovative solutions from drug discovery, leveraging AI
for data analytics to clinical trial management and pharmaceutical
consulting services.
The Swiss Biotech industry once more generated record revenues,
driven by collaboration and licensing deals. Swiss biotech
companies often successfully partner with large pharma companies
and thanks to record numbers of approvals from Swissmedic, EMA,
FDA, and other global regulatory authorities, product sales got a
big boost. Meanwhile, public funding remains dire, private funding
kept up the pace from 2023.
"With its R&D and manufacturing capacity far exceeding its
own needs, Switzerland has
established itself as a trusted partner in bilateral and
multilateral alliances," Michael Altorfer CEO, Swiss Biotech
Association.
Along with their partners, the Swiss Biotech Association,
InnoSuisse and, Switzerland Global Enterprise and their
representatives in the US, the Swiss Business Hub USA bring
the leading-edge innovation that Switzerland is consistently recognized for to
BIO 2024.
Switzerland Global Enterprise with its partner Swissnex in
Boston and New York will be hosting a Swiss reception on
Tuesday June 4th from
5pm to 6:30pm at the Swiss Pavilion,
booth #2111.
• AliraHealth
|
Alira Health provides
global consulting and clinical services
enabled by technology and real-world evidence.
|
• ariadne.ai ag
|
Specializes in
leveraging artificial intelligence for advanced data
analysis in biomedical research.
|
• Bacthera SA
|
Focuses on the
manufacture of live biotherapeutic products
for pharmaceutical clients.
|
• BioAlps Association
|
Acts as a life sciences
cluster promoting networking and
collaboration in the BioAlps community.
|
• Bioengineering AG
|
Provides solutions in
bioprocess engineering, ranging
from development to production scale.
|
• Biopôle SA
|
Operates a life
sciences campus that supports innovation
and development in the healthcare and biotech sectors.
|
• BioVersys AG
|
Engages in the research
and development of drugs that
address antimicrobial resistance.
|
• Business Location Switzerland
|
Promotes Switzerland as
a prime location for business
and investment.
|
• DiNABIOS a DiNAQOR Group Company
|
Specializes in
innovative therapies for patients with
genetic heart diseases.
|
• EPIC Suisse Property Management GmbH
|
Offers comprehensive
property management services
across Switzerland.
|
• InSphero AG
|
Develops and produces
3D microtissues for drug
discovery and toxicity testing.
|
• Kisco Pharma Outsourcing Solutions
|
Provides outsourcing
solutions for pharmaceutical
manufacturing and distribution.
|
• KPMG
|
Offers audit, tax, and
advisory services to help
organizations
|
• Molecular Partners AG
|
Develops a new class of
custom-built protein therapeutics
known as DARPin® molecules.
|
• Novigenix
|
Focuses on developing
and commercializing blood tests
for early cancer detection and precision medicine.
|
• Obaris AG
|
Specializes in the
development and commercialization of
orthopedic and surgical implants.
|
• OM Pharma
|
Engages in the
research, development, and marketing of
medicines in respiratory and vascular diseases.
|
• PDC Therapeutics
|
Focuses on developing
precision drugs for the treatment
of severe and rare diseases.
|
• Superlab Suisse AG
|
Provides high-tech
laboratory services and research
facilities for life sciences companies.
|
• Tigermed Swiss SA
|
Offers clinical trial
management and pharmaceutical
consulting services.
|
• Venture Valuation Inc.
|
Specializes in the
assessment and valuation of growth
companies in the life sciences and technology sectors.
|
• Amphilix
|
Focuses on innovative
technologies for biopharmaceutical
development and production.
|
• Cellestia Biotech AG
|
Specializes in
developing targeted therapies for cancer
and other severe diseases based on modulating gene
expression.
|
• Cellvie
|
Dedicated to advancing
mitochondrial transplantation
therapy to treat acute and chronic degenerative
diseases.
|
• FluoSphera
|
Provides
high-throughput screening services using
innovative fluorescence-based technologies.
|
• Nagi Bioscience
|
Develops the first
Organism-on-Chip technology for
automated and ethical testing of drugs and chemicals.
|
• REM Analytics SA
|
Specializes in
microbiome analytics and solutions for
healthcare and agricultural applications.
|
• Scailyte
|
Uses single-cell
technologies and AI-driven data analysis
to discover biomarkers and advance precision medicine.
|
• Synendos Therapeutics AG
|
Focuses on the
development of breakthrough therapies
for the treatment of central nervous system disorders.
|
• Vandria
|
Offers digital
solutions to enhance the efficiency and
effectiveness of healthcare and medical management.
|
• Alpha Onco
|
Engages in the
development of innovative oncology
treatments.
|
• BioArk
|
Provides infrastructure
and support for startups and
established companies in the life sciences sector.
|
• Ceidos SA
|
Specializes in virtual
reality solutions, primarily for
therapeutic and rehabilitation applications.
|
• Curio Biotech SA
|
Focuses on developing
novel treatments based on cell
secretome for regenerative medicine.
|
• Excellgene
|
Produces
biopharmaceuticals using advanced cell line
engineering and protein production technologies.
|
• Immunskills
|
Offers workshops and
training in immunotherapy and
biological production.
|
• Novochizol SA
|
Develops chitosan-based
formulations to enhance the
delivery of biopharmaceuticals.
|
• Orio Therapeutics
|
Specializes in
developing therapies for respiratory
diseases.
|
• SETI / Canton VS
|
Supports economic
development in Valais, particularly in
the sectors of technology, education, and innovation.
|
• Stämm Biotech
|
Works on bioprocesses
that utilize human stem cells for
regenerative medicine.
|
• Swiss Biotech Center
|
Provides laboratory
services, R&D, and consulting to
foster innovation in biotechnology.
|
• ten23 health Valais Ltd.
|
Offers services in drug
development and manufacturing,
with a focus on sustainable practices.
|
The SWISS BIOTECH companies will be available for media and
partner interviews the entire week.
www.s-ge.com
About Switzerland Global Enterprise
Switzerland
Global Enterprise (S-GE) is the official Swiss organization for
export and investment promotion with around 200 employees at
locations throughout Switzerland
and overseas. S-GE supports Swiss SMEs in their international
business and helps innovative foreign companies to settle in
Switzerland. In doing so, we rely
on a unique network of national and international partners. This
allows us to create added value for our customers and prosperity
for Switzerland. As a non-profit
organization, we provide a public service for our clients on behalf
of the Swiss Confederation (State Secretariat for Economic Affairs
SECO) and the cantons. We operate our 27 offices, the so-called
Swiss Business Hubs, and Trade Points, in 31 countries jointly with
the Federal Department of Foreign Affairs (FDFA). Thanks to our
global network of partners, we also support our customers in many
other countries.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/embracing-international-alliances-swiss-biotech-innovation-on-display-at-the-bio-2024-international-convention-in-san-diego-june-3-6-2024-302152141.html
SOURCE Swiss Business Hub USA